Skip to main content Accessibility help
×
Home
Hostname: page-component-ffbbcc459-p4gdp Total loading time: 0.362 Render date: 2022-03-03T18:53:24.799Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Marginal cost of operating a positron emission tomography center in a regulatory environment

Published online by Cambridge University Press:  25 October 2005

Anderson Chuck
Affiliation:
University of Alberta
Philip Jacobs
Affiliation:
University of Alberta and Institute of Health Economics
J. Wayne Logus
Affiliation:
Cross Cancer Institute
Donald St. Hilaire
Affiliation:
Cross Cancer Institute
Chester Chmielowiec
Affiliation:
University of Alberta and Cross Cancer Institute
Alexander J. B. McEwan
Affiliation:
University of Alberta and Cross Cancer Institute

Abstract

Objectives: Cost studies of positron emission tomography (PET) imaging are important for resource and operational planning; the most relevant cost analysis in this regard is the marginal cost. Operating within a regulatory environment can add considerably to the costs of providing PET services. Previously published research has not examined the marginal cost structure of PET nor have they described the implications of regulatory compliance to operational costs. The purpose of this study was to conduct a comprehensive cost estimation of PET imaging with 18F-fluorodeoxyglucose (18F-FDG) to better identify the fixed and variable cost components, the marginal cost structure, and the added costs of satisfying regulatory requirements.

Methods: Financial data on capital and operating expenses were collected for the PET center at the Cross Cancer Institute in Edmonton, Alberta, Canada.

Results: The total per-service cost for clinical operations ranged between $7,869 (400 annual scans) and $1,231 (3,200 annual scans). The marginal cost for the center remained steady as volume increased up to the throughput capacity.

Conclusions: Results indicate that economies from increased volumes did not arise. Regulatory requirements added significant costs to operating an 18F-FDG-PET center.

Type
GENERAL ESSAYS
Copyright
© 2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Berger M, Gould MK, Barnett PG. 2003 The cost of positron emission tomography in six United States veterans affairs hospitals and two academic health centers. AJR Am J Roentgenol. 181: 359365.Google Scholar
Conti PS, Keppler JS, Halls JM. 1994 Positron emission tomography: A financial and operational analysis. Am J Roentgenol. 162: 12791286.Google Scholar
Eitzman D, Al-Aouar Z, Kanter HL, et al. 1992 Clinical outcome of patients with advanced coronary artery disease after viable studies with positron emission tomography. J Am Coll Cardiol. 20: 559565.Google Scholar
Evens RG, Seigel BA, Welch MJ. 1983 Ter-pogassian MM. Cost analyses of positron emission tomography for clinical use. AJR Am J Roentgenol. 141: 10731076.Google Scholar
Evens RG, Seigel BA, Welch MJ, Ter-pogassian M. 1983 Cost analyses of positron emission tomography for clinical use. AJR Am J Roentgenol. 141: 1073076.Google Scholar
Frick MP, Gupta NC, Sunderland JJ, et al. 1992 Considerations in setting up a positron emission tomography center. Semin Nucl Med. 22: 182188.Google Scholar
Gardner SF, Green JA, Bednarczyk EM, et al. 1992 Principles and clinical applications of positron emission tomography. Am J Hosp Pharm. 49: 14991506.Google Scholar
Jacobs P, Rapaport J. 2002 The economics of health and medical care. 5th ed. Gaithersburg, Maryland: Aspen Publishers, Inc.;
Keppler JS, Conti PS. 2001 A cost analysis of positron emission tomography. AJR Am J Roentgenol. 177: 3140.Google Scholar
Kwee SA, Coel MN, Lim J, Ko JP. 2005 Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 173: 252255.Google Scholar
Lassen U. 2001. Positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG): A survey of the literature with regard to evidence for clinical use in oncology, cardiology and neurology. Alberta, Canada: Centre for Evaluation and Medical Technology Assessment;
Liberati A, Sheldon T, Banta D. 1997 Eur-assess project subgroup report on methodology: Methodological guidance for the conduct of health technology assessment. Int J Technol Assess Health Care. 13: 186219.Google Scholar
Ryu SY, Kim MH, Choi SC, et al. 2003 Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med. 44: 347352.Google Scholar
Strauss LG, Conti PS. 1991 The application of PET in clinical oncology. J Nucl Med. 32: 623648.Google Scholar
Wagner HN, Conti PS. 1991 Advances in medical imaging for cancer diagnosis and treatment. Cancer. 67: 11211128.Google Scholar
15
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Marginal cost of operating a positron emission tomography center in a regulatory environment
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Marginal cost of operating a positron emission tomography center in a regulatory environment
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Marginal cost of operating a positron emission tomography center in a regulatory environment
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *